Zhou, Mei <br/><br/>
Estrogen receptor beta enhances chemotherapy response of GBM cells by down regulating DNA damage response pathways.  [electronic resource] 

 -  Scientific reports  04 2019 
 - 6124 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2045-2322 
<br/><br/><label>Standard No.: </label>10.1038/s41598-019-42313-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents, Alkylating--pharmacology<br/>Apoptosis--drug effects<br/>Ataxia Telangiectasia Mutated Proteins--metabolism<br/>Brain Neoplasms--drug therapy<br/>Cell Cycle Checkpoints--drug effects<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>DNA Damage--drug effects<br/>Down-Regulation<br/>Drug Resistance, Neoplasm--genetics<br/>Estrogen Receptor beta--genetics<br/>Gene Expression Regulation, Neoplastic<br/>Gene Knockout Techniques<br/>Glioblastoma--drug therapy<br/>Histones--metabolism<br/>Humans<br/>Male<br/>Mice<br/>RNA-Seq<br/>Recombinational DNA Repair<br/>Signal Transduction<br/>Temozolomide--pharmacology<br/>Xenograft Model Antitumor Assays